Healthcare provider profile · identity verified

Marilyn A Williams, NP

Nurse Practitioner · BLUE RIDGE, GA · NPI 1881655728

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	310	102
Rosuvastatin Calcium	Rosuvastatin Calcium	275	97
Levothyroxine Sodium	Levothyroxine Sodium	274	86
Lisinopril	Lisinopril	181	63
Sertraline Hcl	Sertraline Hcl	176	54
Metformin Hcl	Metformin Hcl	172	55
Gabapentin	Gabapentin	170	50
Losartan Potassium	Losartan Potassium	168	65
Pantoprazole Sodium	Pantoprazole Sodium	142	44
Amlodipine Besylate	Amlodipine Besylate	138	53
Trazodone Hcl	Trazodone Hcl	131	42
Buspirone Hcl	Buspirone Hcl	128	33
Omeprazole	Omeprazole	126	45
Fluticasone Propionate	Fluticasone Propionate	106	28
Furosemide	Furosemide	95	26
Tamsulosin Hcl	Tamsulosin Hcl	95	26
Ropinirole Hcl	Ropinirole Hcl	94	21
Metoprolol Succinate	Metoprolol Succinate	92	28
Hydrochlorothiazide	Hydrochlorothiazide	91	29
Metoprolol Tartrate	Metoprolol Tartrate	89	27
Potassium Chloride	Potassium Chloride	89	28
Metformin Hcl Er	Metformin Hcl	87	38
Mounjaro	Tirzepatide	85	15
Citalopram Hbr	Citalopram Hydrobromide	72	24
Famotidine	Famotidine	72	27
Zolpidem Tartrate	Zolpidem Tartrate	71	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	69	15
Alendronate Sodium	Alendronate Sodium	66	16
Albuterol Sulfate Hfa	Albuterol Sulfate	64	27
Fluoxetine Hcl	Fluoxetine Hcl	63	23
Azithromycin	Azithromycin	62	41
Prednisone	Prednisone	56	41
Ezetimibe	Ezetimibe	53	14
Simvastatin	Simvastatin	52	20
Meloxicam	Meloxicam	51	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	18
Vitamin D2	Ergocalciferol (Vitamin D2)	46	20
Alprazolam	Alprazolam	45	14
Eliquis	Apixaban	44	12
Pravastatin Sodium	Pravastatin Sodium	44	16
Azelastine Hcl	Azelastine Hcl	43	21
Soliqua 100-33	Insulin Glargine/Lixisenatide	41	suppressed
Montelukast Sodium	Montelukast Sodium	40	13
Tramadol Hcl	Tramadol Hcl	39	16
Donepezil Hcl	Donepezil Hcl	38	13
Bupropion Xl	Bupropion Hcl	37	12
Escitalopram Oxalate	Escitalopram Oxalate	35	13
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Olmesartan Medoxomil	Olmesartan Medoxomil	33	11
Ozempic	Semaglutide	33	11
Carvedilol	Carvedilol	32	13
Doxycycline Hyclate	Doxycycline Hyclate	31	26
Memantine Hcl	Memantine Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Ibuprofen	Ibuprofen	28	12
Farxiga	Dapagliflozin Propanediol	27	suppressed
Atenolol	Atenolol	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	15
Clonazepam	Clonazepam	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Estradiol	Estradiol	23	suppressed
Linzess	Linaclotide	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Finasteride	Finasteride	21	suppressed
Levemir Flexpen	Insulin Detemir	21	suppressed
Mupirocin	Mupirocin	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Lovastatin	Lovastatin	17	suppressed
Naproxen	Naproxen	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Topiramate	Topiramate	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Nexlizet	Bempedoic Acid/Ezetimibe	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Torsemide	Torsemide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Gemtesa	Vibegron	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Metformin Er Gastric	Metformin Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Risperidone	Risperidone	11	suppressed
Testosterone	Testosterone	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error